Production of interferon-β by fibroblast cells on membranes prepared with RGD-containing peptidesHIGUCHI, Akon; TAKANASHI, Yasunari; TSUZUKI, Nobuya et al.Journal of biomedical materials research. 2003, Vol 65A, Num 3, pp 369-378, issn 0021-9304, 10 p.Article

Production of interferon-β by fibroblast cells on membranes prepared by extracellular matrix proteinsHIGUCHI, Akon; TAKANASHI, Yasunari; OHNO, Takeshi et al.Cytotechnology (Dordrecht). 2002, Vol 39, Num 3, pp 131-137, issn 0920-9069, 7 p.Article

Ein neues Verfahren zur Aufarbeitung von Interferon-β = Nouveau procédé de préparation d'interféron β = A new process for the β interferon preparationMENGE, U; MORR, M; KULA, M.-R et al.Dechema-Monographien. 1984, Vol 95, Num 1932-1958, issn 0070-315X, 221Article

Adherence to interferon-beta treatment and results of therapy switchingCLERICO, Marinella; BARBERO, Pierangelo; CONTESSA, Giulia et al.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 104-108, issn 0022-510X, 5 p.Conference Paper

Multiple protein-DNA interactions within the human interferon-β regulatory elementXANTHOUDAKIS, S; COHEN, L; HISCOTT, J et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 2, pp 1139-1145, issn 0021-9258Article

Preliminary analysis of a trial of pulse cyclophosphamide in IFN-β-resistant active MSSMITH, Derek.Journal of the neurological sciences. 2004, Vol 223, Num 1, pp 73-79, issn 0022-510X, 7 p.Conference Paper

Corticosteroids treatmentPOZZILLI, Carlo; MARINELLI, Fabiana; ROMANO, Silvia et al.Journal of the neurological sciences. 2004, Vol 223, Num 1, pp 47-51, issn 0022-510X, 5 p.Conference Paper

Serum levels of IL-17A in patients with relapsing―remitting multiple sclerosis treated with interferon-βBALASA, Rodica; BAJKO, Zoltan; HUTANU, Adina et al.Multiple sclerosis. 2013, Vol 19, Num 7, pp 885-890, issn 1352-4585, 6 p.Article

Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experienceZANOTTI, Cinzia; GHIDINI, Claudia; LAMORGESE, Cinzia et al.Clinical chemistry and laboratory medicine. 2010, Vol 48, Num 9, pp 1235-1238, issn 1434-6621, 4 p.Article

Early treatment: PreCISe-ly what the patient needsMONTALBAN, Xavier.Journal of the neurological sciences. 2009, Vol 287, issn 0022-510X, S2-S6, SUP1Conference Paper

Inhibition of ganciclovir -resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine)MURAYAMA, Tsugiya; YAMAGUCHI, Nobuo; IWAMOTO, Kozo et al.Antiviral chemistry & chemotherapy. 2006, Vol 17, Num 1, pp 11-16, issn 0956-3202, 6 p.Article

Interferon-β treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activityHELLMAN, Karin; ROOS, Ewa; ÖSTERLUND, Anna et al.British journal of clinical pharmacology. 2003, Vol 56, Num 3, pp 337-340, issn 0306-5251, 4 p.Article

Phase II study of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme : experience of the Kyoto Neuro-Oncology GroupAOKI, Tomokazu; TAKAHASHI, Jun A; UEBA, Tetsuya et al.Journal of neurosurgery. 2006, Vol 105, Num 3, pp 385-391, issn 0022-3085, 7 p.Article

Interferon-β_1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosisKRAUS, Joerg; BAUER, Roland; TRAUPE, Horst et al.Journal of neurology. 2004, Vol 251, Num 4, pp 464-472, issn 0340-5354, 9 p.Article

CD45RA + ICAM-3+ lymphocytes in interferon-β1b-treated and -untreated patients with relapsing-remitting multiple sclerosisCHATZIMANOLIS, N; KRAUS, J; VOIGT, K et al.Acta neurologica scandinavica. 2004, Vol 110, Num 6, pp 377-385, issn 0001-6314, 9 p.Article

Schwere Exazerbation einer chronischen Hepatitis B unter Therapie mit Kortikosteroiden und Lamivudin und erfolgreiche Kurzzeit-Kombinationstherapie mit Interferon-β und -γ = Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-β and interferon-γMUSCH, E; MALEK, M; CHRISSAFIDOU, A et al.Zeitschrift für Gastroenterologie. 2003, Vol 41, Num 5, pp 425-428, issn 0044-2771, 4 p.Article

Aspergillus fumigatus conidia induce interferon-β signalling in respiratory epithelial cellsBEISSWENGER, C; HESS, C; BALS, R et al.The European respiratory journal. 2012, Vol 39, Num 2, pp 411-418, issn 0903-1936, 8 p.Article

Serum from interferon-β-Ib-treated patients with early multiple sclerosis stabilizes the blood―brain barrier in vitroMÜLLER, Marcus; FRESE, Achim; NASSENSTEIN, Isabelle et al.Multiple sclerosis. 2012, Vol 18, Num 2, pp 236-239, issn 1352-4585, 4 p.Article

Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cellsIMAIZUMI, Tadaatsu; TANAKA, Hiroshi; MATSUMIYA, Tomoh et al.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 11, pp 3534-3539, issn 0931-0509, 6 p.Article

Interferon-β stabilizes barrier characteristics of the blood-brain barrier in four different species in vitroKRAUS, J; VOIGT, K; SCHULLER, A. M et al.Multiple sclerosis. 2008, Vol 14, Num 6, pp 843-852, issn 1352-4585, 10 p.Article

Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-βOZAWA, Shutaro; WEIXIN LU; BUCANA, Corazon D et al.International journal of oncology. 2003, Vol 22, Num 5, pp 977-984, issn 1019-6439, 8 p.Article

Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-β1a or glatiramer acetate compared with untreated patientsJANSSON, A; ERNERUDH, J; KVARNSTRÖM, M et al.Multiple sclerosis. 2003, Vol 9, Num 5, pp 440-445, issn 1352-4585, 6 p.Article

Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytesAKAZAWA, Yukiko; KAWAGUCHI, Hiroko; FUNAHASHI, Maki et al.Journal of pharmaceutical sciences. 2002, Vol 91, Num 10, pp 2110-2115, issn 0022-3549, 6 p.Article

Antitumor Therapeutic Effects of Cytosine Deaminase and Interferon-β Against Endometrial Cancer Cells Using Genetically Engineered Stem Cells In VitroYI, Bo-Rim; KANG, Nam-Hee; HWANG, Kyung-A et al.Anticancer research. 2011, Vol 31, Num 9, pp 2853-2861, issn 0250-7005, 9 p.Article

Benefits of Interferon-β and Temozolomide Combination Therapy for Newly Diagnosed Primary Glioblastoma With the Unmethylated MGMT Promoter: A Multicenter StudyMOTOMURA, Kazuya; NATSUME, Atsushi; KISHIDA, Yugo et al.Cancer. 2011, Vol 117, Num 8, pp 1721-1730, issn 0008-543X, 10 p.Article